Evidence map›Paper›PMID 30160183›Full record

Trial reportThe British journal of radiology2018

Contrast dose reduction with shortened injection durations in coronary CT angiography on 16-cm Wide-detector CT scanner.

Ting-Ting Qu, Jian-Ying Li, Xi-Jun Jiao, Xiang-Li Zhang, Zhe-Fan Song, Yin-Xia Guo, Jian-Xin Guo

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in The British journal of radiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ting-Ting Qu1 Department of Radiology, The First Affiliated Hospital of Xi'an Jiaotong University , Xi'an , PR China.
Jian-Ying Li2 CT Research Center, GE Healthcare China , Beijing , China.
Xi-Jun Jiao1 Department of Radiology, The First Affiliated Hospital of Xi'an Jiaotong University , Xi'an , PR China.
Xiang-Li Zhang1 Department of Radiology, The First Affiliated Hospital of Xi'an Jiaotong University , Xi'an , PR China.
Zhe-Fan Song1 Department of Radiology, The First Affiliated Hospital of Xi'an Jiaotong University , Xi'an , PR China.
Yin-Xia Guo1 Department of Radiology, The First Affiliated Hospital of Xi'an Jiaotong University , Xi'an , PR China.
Jian-Xin Guo1 Department of Radiology, The First Affiliated Hospital of Xi'an Jiaotong University , Xi'an , PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectives: To investigate the use of shortened contrast injection with late triggering in coronary CT angiography (CCTA) for decreasing contrast dose and maintaining image quality.

methods: 106 patients for CCTA on a 16-cm wide-detector CT were prospectively enrolled into groups A (n = 50) and B (n = 56) randomly. Patient weight-dependent contrast medium (Iopamiro, 370 mgI ml

results: There was no difference in the injection rate and enhancement duration between the two groups (p > 0.05), while the total contrast dose in group A (36.2 ± 5.7 ml) was significantly lower than in group B (46.4 ± 6.3 ml) (p < 0.001). There was no difference for CT values in all major coronary vessels between the two groups and no difference in subjective image quality scores (all p > 0.05).

conclusion: It is feasible to shorten contrast injection to 8 s in CCTA on wide-detector CT systems to significantly reduce contrast dosage, maintain adequate enhancement and reduce contrast-related artifacts. ADVANCES IN KNOWLEDGE:: (1) Coronary CT angiography (CCTA) scans with shortened contrast medium injection duration and late triggering are feasible with a 16-cm wide-detector CT system (2) Compared with the conventional CCTA with 10 s contrast injection duration, the new contrast injection protocol of using shortened injection duration (to 8 s) and late triggering reduces contrast dose to 36.2 ml, while maintaining adequate enhancement in vessels and reducing contrast-related artifacts.

Indexed as

AdultAgedAged, 80 and overArtifactsComputed Tomography AngiographyContrast MediaCoronary AngiographyCoronary VesselsFemaleHumansInjections, IntravenousIopamidolMaleMiddle AgedProspective StudiesContrast MediaIopamidol

Identifiers

PMID30160183
PMCPMC6319827

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.